Active substances
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| GANFORT EYE DROPS | 5,0.3 mg/ml,mg/ml | Eye drops, solution · Ophthalmic use | 1 Dropper Container | SAR 51.05 | NCE · Prescription | ABBVIE Deutschland GmbH | Valid |
| GANFORT EYE DROPS | 5,0.3 mg/ml,mg/ml | Eye drops, solution · Ophthalmic use | 30 Single Dose Container | SAR 72.30 | NCE · Prescription | ABBVIE Deutschland GmbH | Valid |
OPEN ANGLE GLUCOMA
Reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops | £5.81 | 3 ml | 1 Oct 2026 |
| NHS Drug Tariff | Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops 0.4ml unit dose preservative free | £17.94 | 30 unit dose | 1 Oct 2026 |
| NHS Drug Tariff | Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops preservative free | £14.16 | 3 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.